{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:59:25Z","timestamp":1792191565008,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2013-02355546"],"award-info":[{"award-number":["GR-2013-02355546"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2011-02348048"],"award-info":[{"award-number":["GR-2011-02348048"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2011-02348048"],"award-info":[{"award-number":["GR-2011-02348048"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12916-019-1298-5","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:02:47Z","timestamp":1553612567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Irene","family":"Tramacere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio B.","family":"Boncoraglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Banzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Del Giovane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koren H.","family":"Kwag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Moja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"issue":"12","key":"1298_CR1","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","volume":"45","author":"JF Meschia","year":"2014","unstructured":"Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(12):3754\u2013832.","journal-title":"Stroke."},{"key":"1298_CR2","volume-title":"The top 10 causes of death","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. The top 10 causes of death. 2018. \n                    http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death\n                    \n                  . Accessed 31 May 2018."},{"issue":"12","key":"1298_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","volume":"6","author":"MF Giles","year":"2007","unstructured":"Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063\u201372.","journal-title":"Lancet Neurol"},{"issue":"16","key":"1298_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","volume":"374","author":"P Amarenco","year":"2016","unstructured":"Amarenco P, Lavall\u00e9e PC, Labreuche J, Albers GW, Bornstein NM, Canh\u00e3o P, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374(16):1533\u201342.","journal-title":"N Engl J Med"},{"issue":"20","key":"1298_CR5","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1056\/NEJMcp1107281","volume":"366","author":"SM Davis","year":"2012","unstructured":"Davis SM, Donnan GA. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med. 2012;366(20):1914\u201322.","journal-title":"N Engl J Med"},{"issue":"7","key":"1298_CR6","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association\/American stroke association. Stroke. 2014;45(7):2160\u2013236.","journal-title":"Stroke."},{"issue":"9596","key":"1298_CR7","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0140-6736(07)61448-2","volume":"370","author":"PM Rothwell","year":"2007","unstructured":"Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432\u201342.","journal-title":"Lancet."},{"issue":"6","key":"1298_CR8","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/STROKEAHA.106.475525","volume":"38","author":"DG Hackam","year":"2007","unstructured":"Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38(6):1881\u20135.","journal-title":"Stroke."},{"issue":"10059","key":"1298_CR9","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","volume":"388","author":"R Collins","year":"2016","unstructured":"Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532\u201361.","journal-title":"Lancet."},{"key":"1298_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"1298_CR11","unstructured":"Giorgio Boncoraglio, Cinzia Del Giovane, Alessandro Squizzato, Lorenzo Moja, Irene Tramacere. Statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a network meta-analysis. PROSPERO 2018 CRD42018079112 Available from: \n                    http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=CRD42018079112\n                    \n                  ."},{"issue":"11","key":"1298_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"1298_CR13","first-page":"CD002091","volume":"3","author":"BN Manktelow","year":"2009","unstructured":"Manktelow BN, Potter JF. Interventions in the management of serum lipids for preventing stroke recurrence. Cochrane Database Syst Rev. 2009;3:CD002091.","journal-title":"Cochrane Database Syst Rev"},{"key":"1298_CR14","first-page":"CD007551","volume":"8","author":"A Squizzato","year":"2011","unstructured":"Squizzato A, Romualdi E, Dentali F, Ageno W. Statins for acute ischemic stroke. Cochrane Database Syst Rev. 2011;8:CD007551.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1298_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80\u201397.","journal-title":"Res Synth Methods"},{"issue":"7","key":"1298_CR16","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015;46(7):2032\u201360.","journal-title":"Stroke."},{"issue":"7","key":"1298_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.7326\/0003-4819-148-7-200804010-00011","volume":"148","author":"G Salanti","year":"2008","unstructured":"Salanti G, Kavvoura FK, Ioannidis JP. Exploring the geometry of treatment networks. Ann Intern Med. 2008;148(7):544\u201353.","journal-title":"Ann Intern Med"},{"key":"1298_CR18","unstructured":"Higgins JPT, Altman DG, Sterne JAC, eds. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from \n                    www.handbook.cochrane.org\n                    \n                  ."},{"key":"1298_CR19","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013: The GRADE Working Group; 2013. Available from \n                    guidelinedevelopment.org\/handbook"},{"issue":"7","key":"1298_CR20","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","volume":"9","author":"G Salanti","year":"2014","unstructured":"Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 2014;9(7):e99682.","journal-title":"PLoS One"},{"issue":"2","key":"1298_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163\u201371.","journal-title":"J Clin Epidemiol"},{"issue":"7414","key":"1298_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ."},{"issue":"3","key":"1298_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ije\/dys041","volume":"41","author":"RM Turner","year":"2012","unstructured":"Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane database of systematic reviews. Int J Epidemiol. 2012;41(3):818\u201327.","journal-title":"Int J Epidemiol"},{"issue":"25 Suppl 2","key":"1298_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S1\u2013S45.","journal-title":"Circulation."},{"issue":"8","key":"1298_CR25","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1298_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64\u201375.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1298_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","volume":"38","author":"J Brok","year":"2009","unstructured":"Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive--trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38(1):287\u201398.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1298_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ije\/dyn179","volume":"38","author":"K Thorlund","year":"2009","unstructured":"Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38(1):276\u201386.","journal-title":"Int J Epidemiol"},{"issue":"47","key":"1298_CR29","first-page":"1","volume":"8","author":"A Tobias","year":"1999","unstructured":"Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8(47):1\u201348.","journal-title":"Stata Tech Bull"},{"issue":"2","key":"1298_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/01.CIR.99.2.216","volume":"99","author":"JF Plehn","year":"1999","unstructured":"Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the cholesterol and recurrent events (CARE) study. The Care Investigators. Circulation. 1999;99(2):216\u201323.","journal-title":"Circulation."},{"issue":"5","key":"1298_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJM200008033430502","volume":"343","author":"HD White","year":"2000","unstructured":"White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D, et al. Pravastatin therapy and the risk of stroke. N Engl J Med. 2000;343(5):317\u201326.","journal-title":"N Engl J Med"},{"issue":"9411","key":"1298_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","volume":"363","author":"R Collins","year":"2004","unstructured":"Collins R, Armitage J, Parish S, Sleight P, Peto R. Heart protection study collaborative group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363(9411):757\u201367.","journal-title":"Lancet."},{"issue":"6","key":"1298_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549\u201359.","journal-title":"N Engl J Med"},{"issue":"11","key":"1298_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","volume":"6","author":"J Kennedy","year":"2007","unstructured":"Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, Investigators FASTER. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6(11):961\u20139.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1298_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.20996\/1819-6446-2012-8-1-4-16","volume":"8","author":"VV Yakusevich","year":"2012","unstructured":"Yakusevich VV, Malygin AY, Lychenko SV, Petrochenko AS, Kabanov AV. The efficacy of high-dose simvastatin in acute period of ischemic stroke. Ration Pharmacother Cardiol. 2012;8(1):4\u201316.","journal-title":"Ration Pharmacother Cardiol"},{"issue":"9","key":"1298_CR36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ebiom.2015.08.006","volume":"2","author":"N Hosomi","year":"2015","unstructured":"Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, et al. The Japan statin treatment against recurrent stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study. EBioMedicine. 2015;2(9):1071\u20138.","journal-title":"EBioMedicine."},{"issue":"2","key":"1298_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.atherosclerosis.2015.02.021","volume":"239","author":"Y Ueno","year":"2015","unstructured":"Ueno Y, Yamashiro K, Tanaka Y, Watanabe M, Miyamoto N, Shimada Y, et al. Rosuvastatin may stabilize atherosclerotic aortic plaque: transesophageal echocardiographic study in the EPISTEME trial. Atherosclerosis. 2015;239(2):476\u201382.","journal-title":"Atherosclerosis."},{"issue":"1","key":"1298_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5853\/jos.2015.01578","volume":"18","author":"JH Heo","year":"2016","unstructured":"Heo JH, Song D, Nam HS, Kim EY, Kim YD, Lee KY, et al. Effect and safety of rosuvastatin in acute ischemic stroke. J Stroke. 2016;18(1):87\u201395.","journal-title":"J Stroke"},{"issue":"11","key":"1298_CR39","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1161\/STROKEAHA.116.014600","volume":"47","author":"J Montaner","year":"2016","unstructured":"Montaner J, Bustamante A, Garc\u00eda-Matas S, Mart\u00ednez-Zabaleta M, Jim\u00e9nez C, de la Torre J, et al. Combination of thrombolysis and statins in acute stroke is safe: results of the STARS randomized trial (stroke treatment with acute reperfusion and simvastatin). Stroke. 2016;47(11):2870\u20133.","journal-title":"Stroke."},{"issue":"12","key":"1298_CR40","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1161\/STROKEAHA.107.493106","volume":"38","author":"P Amarenco","year":"2007","unstructured":"Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A 3rd, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke. 2007;38(12):3198\u2013204.","journal-title":"Stroke."},{"issue":"6","key":"1298_CR41","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1371\/journal.pmed.0040184","volume":"4","author":"L Bero","year":"2007","unstructured":"Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med. 2007;4(6):e184.","journal-title":"PLoS Med"},{"key":"1298_CR42","doi-asserted-by":"publisher","first-page":"g5949","DOI":"10.1136\/bmj.g5949","volume":"349","author":"L Bero","year":"2014","unstructured":"Bero L. Bias related to funding source in statin trials. BMJ. 2014;349:g5949.","journal-title":"BMJ."},{"issue":"6","key":"1298_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/eci.12264","volume":"44","author":"L Moja","year":"2014","unstructured":"Moja L, Pecoraro V, Ciccolallo L, Dall'Olmo L, Virgili G, Garattini S. Flaws in animal studies exploring statins and impact on meta-analysis. Eur J Clin Investig. 2014;44(6):597\u2013612.","journal-title":"Eur J Clin Investig"},{"issue":"9","key":"1298_CR44","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/eci.12304","volume":"44","author":"V Pecoraro","year":"2014","unstructured":"Pecoraro V, Moja L, Dall'Olmo L, Cappellini G, Garattini S. Most appropriate animal models to study the efficacy of statins: a systematic review. Eur J Clin Investig. 2014;44(9):848\u201371.","journal-title":"Eur J Clin Investig"},{"issue":"1","key":"1298_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","volume":"19","author":"M Schachter","year":"2005","unstructured":"Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19(1):117\u201325.","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"1298_CR46","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/WNL.62.4.670","volume":"62","author":"JP Dreier","year":"2004","unstructured":"Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by grapefruit consumption. Neurology. 2004;62(4):670.","journal-title":"Neurology."},{"issue":"3","key":"1298_CR47","first-page":"323","volume":"11","author":"PJ Neuvonen","year":"2010","unstructured":"Neuvonen PJ. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics. Curr Opin Investig Drugs. 2010;11(3):323\u201332.","journal-title":"Curr Opin Investig Drugs"},{"issue":"5","key":"1298_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1474-4422(09)70058-4","volume":"8","author":"P Amarenco","year":"2009","unstructured":"Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8(5):453\u201363.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1298_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11739-017-1650-8","volume":"12","author":"JX Fang","year":"2017","unstructured":"Fang JX, Wang EQ, Wang W, Liu Y, Cheng G. The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review. Intern Emerg Med. 2017;12(5):679\u201387.","journal-title":"Intern Emerg Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1298-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:05:55Z","timestamp":1585094755000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1298-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1298-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"18 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"67"}}